[ Price : $8.95]
FDA warns Los Angeles, CA-based DSP Skin Care about CGMP and other violations, some repeated from 2018, in its manufacturing of fi...[ Price : $8.95]
Allarity Therapeutics says it is no longer economically feasible to pursue its dovitinib as a monotherapy for some renal cancers a...[ Price : $8.95]
FDA publishes a draft guidance on the electronic submission of expedited individual case safety reports from IND-exempt BA/BE stud...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Policy Regarding N-acetyl-L-cysteine.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Genentechs Rozlytrek tablet...[ Price : $8.95]
Federal Register notice: FDA permanently debars Duniel Tejeda from providing services in any capacity to a person that has an appr...[ Price : $8.95]
The Senate Appropriations Committee posts its fiscal year 2023 proposed budget bill for FDA that increases the agencys spending by...[ Price : $8.95]
An Amgen study says the FDA accelerated approval program is working well and should not be changed because there are some drug out...